PlainVisa
2026 data Public-data reference Official source

Novartis Institutes for BioMedical Research, Inc.

A DOL Labor Condition Application record spanning FY2023–2026. Review the filing volume, DOL certification record, and offered-wage context below.

DOL LCA filings
368
DOL-certified
99.7%
Median offered wage
$102,099

East Hanover, NJ NAICS: 541714

How many H-1B LCA filings list Novartis Institutes for BioMedical Research, Inc.?

U.S. Department of Labor's OFLC discloses 368 Labor Condition Application filings naming Novartis Institutes for BioMedical Research, Inc. from FY2023 through FY2026, drawn directly from DOL's quarterly public disclosure releases. An LCA is the wage-and-working-conditions attestation an employer files with DOL before petitioning USCIS for an H-1B worker: it is a filing record, not a USCIS approval, a job offer, or a confirmed hire, and the count reflects filings, not people, since an employer sponsoring the same role at more than one worksite, or refiling across fiscal years, is counted once per filing. See filing history · Recent LCAs

How many H-1B petitions has USCIS approved for Novartis Institutes for BioMedical Research, Inc.?

Separate from the DOL filing record above, U.S. Citizenship and Immigration Services adjudicated 99 H-1B petitions naming Novartis Institutes for BioMedical Research, Inc. through FY2024, and approved the large majority of them: 96% approved (95 approvals, 4 denials). A DOL certification is the labor-condition step filed before a petition; this USCIS figure is the actual adjudicated outcome, and the two rates commonly differ.

The verdict

Novartis Institutes for BioMedical Research, Inc. is listed in 368 DOL LCA filings, among the largest employer filers by filing volume in this extract. DOL certified 99.7% of those LCAs; the median listed offered wage is $102,099. This is not a USCIS approval, hiring, or sponsorship ranking.

368
DOL LCA filings, FY2023–FY2026
99.7%
DOL-certified
$102,099
median offered wage
Top 1%
of employer filers by volume

According to U.S. Department of Labor OFLC LCA disclosure files (FY2023–FY2026). Based in East Hanover, NJ.

Saved on this device only, no account, no email. Open saved list Follow this profile's data updates Updates when the published DOL data vintage changes; this is a feed, not an alert service.

Novartis Institutes for BioMedical Research, Inc. vs all U.S. employer filers by LCA volume

Where this employer's disclosed Labor Condition Application count sits among every tracked employer filer (inventory signal, not a sponsorship ranking)

368 587th of 122824 higher than 122,237 of 122,824 employer filers

Employer filers, banded by disclosed H-1B LCA filing count

Each bar is a band; taller bars hold more employer filers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source U.S. Department of Labor OFLC · FY2023–FY2026

LCA filing shape · Novartis Institutes for BioMedical Research

Derived from this employer's disclosed LCAs on file (FY2023–FY2026), title mix and worksite counties, not national boilerplate. LCA filings do not establish USCIS outcomes or confirmed hiring.

Offered-wage span on file: $56,888$239,200 .

Title concentration

  • Senior Scientist I 71 · 19.3% · $95,962
  • Senior Scientist II 66 · 17.9% · $104,731
  • Principal Scientist I 59 · 16% · $112,437
  • Research Scientist II 46 · 12.5% · $87,196
  • Research Scientist I 19 · 5.2% · $70,074

Worksite counties

  • CAMBRIDGE CITY, MA 42 · 82.4%
  • SAN DIEGO, CA 7 · 13.7%
  • ALAMEDA, CA 2 · 3.9%

DOL LCA release change

What changed between the two LCA fiscal years

FY2024 -> FY2025
  • Novartis Institutes for BioMedical Research, Inc.'s disclosed H-1B LCA filing count fell from 106 in FY2024 to 92 in FY2025 (-13.2%).

Arithmetic differences between stored DOL OFLC Labor Condition Application disclosure fiscal years for this employer identity - not a headcount, hire forecast, or cause claim. Role mix can shift between years even when the filing total is flat. Totals group name variants that share the same identity key.

National filing changes Two-year CSV

National-scale filing footprint

Novartis Institutes for BioMedical Research, Inc. has filed 368 LCAs (more volume than 100% of U.S. employer filers in this extract). DOL certification: 99.7%. Worksites span 2 states , led by MA.

High DOL certification volume

Novartis Institutes for BioMedical Research, Inc. certified 99.7% of 368 LCAs (367 certified). That is a Labor Department attestation signal, not a USCIS approval rate. Wage range on file: $56,888–$239,200.

Certification Rate

99.7%

Very high DOL cert

Avg. Salary

$102,099

Near portal avg

Total Workers

368

Moderate worker count

Compare with another employer filer

Novartis Institutes for BioMedical Research, Inc. vs a peer vs the national average, from DOL LCA data.

Avg. offered wage$102,099 · 32% lower than Ernst & Young US LLP
This filer
Peer
$149,512
National avg.
$113,357
Certification rate99.7% · 2% higher than Ernst & Young US LLP
This filer
Peer
97.6%
National avg.
97.7%
Total LCA filings368 · 99% lower than Ernst & Young US LLP
This filer
Peer
39,678
National avg.
17
FY2025 filings are 72% of FY2023

127 completed-year filings in FY2023, 92 in FY2025. The scale spans up to twice the earlier year's count: the midpoint is unchanged and the endpoint is at least doubled.

Wondering how long it takes USCIS to process an H-1B petition for this employer? See current I-129 processing times →

Salary Analysis

Compensation range for H-1B positions at Novartis Institutes for BioMedical Research, Inc.

Minimum
$56,888
Maximum
$239,200
Average Salary
$102,099

LCA Filing History

H-1B LCA filing trends from FY2023 to FY2026

FY2023 127 LCA filings · 99.2% DOL-certified · $98,703 avg
FY2024 106 LCA filings · 100% DOL-certified · $104,192 avg
FY2025 92 LCA filings · 100% DOL-certified · $103,946 avg

FY2026 is partial on this extract. Chart shows completed fiscal years only (through FY2025).

Top Occupations

Most frequently listed job titles at Novartis Institutes for BioMedical Research, Inc.

Job Title LCA filings Avg. Salary
Senior Scientist I 71 $95,962
Senior Scientist II 66 $104,731
Principal Scientist I 59 $112,437
Research Scientist II 46 $87,196
Research Scientist I 19 $70,074
Discovery Postdoctoral Fellow 11 $71,125
Principal Scientist II 10 $126,765
Senior Expert I Data Science 9 $118,504
Innovation Postdoctoral Fellow 8 $69,002
Principal Scientist 7 $117,847
Senior Expert II Data Science 3 $128,031
Senior Expert I, Data Science 3 $117,610
Translational Project Manager 2 $130,624
Senior Scientist III 2 $119,517
Senior Principal Software Engineer 2 $129,189

Geographic Distribution

Where Novartis Institutes for BioMedical Research, Inc. places H-1B workers across the United States

MA 78 LCA filings
CA 22 LCA filings

Nationwide peers near Novartis Institutes for BioMedical Research's 368-LCA band

Cross-state DOL neighbors for Novartis Institutes for BioMedical Research, Inc. - LCA filing-count and offered-wage axes, outside NJ.

Similar LCA filing volume

Nearest cross-state employer filers by LCA filing count (368 here; floor ≥10 LCA filings).

Similar avg offered wage

Cross-state employer filers with a comparable average listed offered wage ($102,099 here).

Disclaimer: Informational only, not professional advice.

Read with Novartis Institutes for BioMedical Research

ABS(total_petitions) peers first, then a LARGEST-distance pole and a stamp-branched drill, not a fixed Related strip. This page stamps MID-BOOK · CERT-LOCK · WAGE-BELOW.

What to do with this profile

Use the DOL LCA record for Novartis Institutes for BioMedical Research, Inc. to compare filing volume and offered wages, not USCIS outcomes.

DOL disclosure data only. Not legal advice, sponsorship guarantees, or visa eligibility.

Every figure on PlainVisa is rendered directly from federal source data, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error. Data current as of 2026-09-09.